| Presenter: |
| Katherine Lepik BSc(Pharm), MSc Clinical Pharmacist Research Coordinator, BC- CfE Pharmacovigilance Initiative |
Pharmacovigilance: Antiretroviral drug safety monitoring in BC
- Learning Series
| Presenter: |
| Katherine Lepik BSc(Pharm), MSc Clinical Pharmacist Research Coordinator, BC- CfE Pharmacovigilance Initiative |
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below